14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $96.99 Wednesday, 1st May 2024 BPMC stock ended at $94.86. This is 3.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.11% from a day low at $90.85 to a day high of $96.40.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
May 01, 2024 $91.44 $96.40 $90.85 $94.86 881 048
Apr 30, 2024 $91.45 $93.00 $90.75 $91.34 516 409
Apr 29, 2024 $93.52 $94.86 $91.12 $93.10 612 793
Apr 26, 2024 $92.76 $94.98 $90.47 $93.00 710 386
Apr 25, 2024 $89.54 $91.46 $88.46 $90.73 752 594
Apr 24, 2024 $91.78 $93.74 $90.43 $92.26 506 112
Apr 23, 2024 $90.48 $94.67 $89.19 $92.29 767 342
Apr 22, 2024 $87.76 $92.66 $86.52 $90.61 712 327
Apr 19, 2024 $88.45 $89.90 $84.62 $86.85 786 370
Apr 18, 2024 $87.93 $91.76 $86.56 $88.90 719 632
Apr 17, 2024 $87.31 $89.69 $86.78 $88.38 727 990
Apr 16, 2024 $84.51 $88.08 $84.44 $86.09 392 332
Apr 15, 2024 $87.18 $87.84 $84.38 $85.18 506 376
Apr 12, 2024 $92.59 $93.00 $87.06 $87.25 472 753
Apr 11, 2024 $91.47 $92.55 $90.44 $92.25 385 529
Apr 10, 2024 $88.13 $90.58 $84.55 $90.49 569 839
Apr 09, 2024 $92.27 $93.93 $91.34 $92.20 710 321
Apr 08, 2024 $92.33 $93.21 $90.57 $91.54 313 646
Apr 05, 2024 $90.00 $91.76 $88.23 $91.65 464 748
Apr 04, 2024 $93.21 $93.31 $90.63 $90.68 486 108
Apr 03, 2024 $90.42 $93.30 $90.31 $92.23 500 111
Apr 02, 2024 $94.18 $94.49 $90.50 $91.56 553 583
Apr 01, 2024 $95.00 $96.99 $93.70 $96.42 455 556
Mar 28, 2024 $95.00 $95.98 $93.75 $94.86 602 986
Mar 27, 2024 $90.08 $94.91 $89.12 $94.79 557 253
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT